Press Resease

Prescription Dermatology Therapeutics Market - Global Industry Analysis

Prescription Dermatology Therapeutics Market by Product Type (Psoriasis Drugs, Acne and Rosacea Drugs, Dermatitis and Seborrhea Drugs, Skin Cancer, and Fungal Infection Drugs) and by Distribution Channel (Mail Order Pharmacies, Retail Pharmacies, and Hospital Pharmacies): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024

Published Date: 02-Jan-2019 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-3688 Status : Published

Global prescription dermatology therapeutics market expected to generate around USD 53.9 billion by 2024, at a CAGR of around 9.9% between 2018 and 2024. Skin is vulnerable to a wide variety of toxins and microbes as it is the largest and most exposed organ. Prolonged exposure of skin to toxins results in various kinds of skin disorders.

Description

The report covers a forecast and an analysis of the prescription dermatology therapeutics market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the prescription dermatology therapeutics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the prescription dermatology therapeutics market on a global and regional level.

In order to give the users of this report a comprehensive view of the prescription dermatology therapeutics market, we have included a competitive landscape and an analysis of Porter’s Five Forces model. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Prescription Dermatology Therapeutics Market

The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product type launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the prescription dermatology therapeutics market on a global and regional basis.

The study provides a decisive view of the prescription dermatology therapeutics market by segmenting the market based on product type, distribution channel, and region. The segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. By product type, the prescription dermatology therapeutics market includes psoriasis drugs, acne and rosacea drugs, dermatitis and seborrhea drugs, skin cancer, and fungal infection drugs. The distribution channel segment includes mail order pharmacies, retail pharmacies, and hospital pharmacies.

The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further divided into major countries, such as the U.S., Canada, Germany, France, UK, China, Japan, India, and Brazil.

The report also includes detailed profiles of various end players, such as Novartis AG, AbbVie, Inc., Amgen, Inc., Janssen Biotech, Inc., Celgene Corporation, Eli Lilly and Company, Pfizer, Inc., Bausch Health Companies, Inc., LEO Pharma A/S, Aurobindo Pharma Ltd., Sun Pharmaceuticals Ltd., and Aclaris Therapeutics, Inc., among others.

This report segments the global prescription dermatology therapeutics market into:

Global Prescription Dermatology Therapeutics Market: By Product Type

  • Psoriasis Drugs
  • Acne and Rosacea Drugs
  • Dermatitis and Seborrhea Drugs
  • Skin Cancer
  • Fungal Infection Drugs

Global Prescription Dermatology Therapeutics Market: By Distribution Channel

  • Mail Order Pharmacies 
  • Retail Pharmacies
  • Hospital Pharmacies

Global Prescription Dermatology Therapeutics Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Prescription Dermatology Therapeutics market, 2017-2024(USD Billion)
    • 2.2. Global Prescription Dermatology Therapeutics market: Snapshot
  •  
  • Chapter 3. Prescription Dermatology Therapeutics Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Prescription Dermatology Therapeutics market drivers: Impact analysis
      • 3.2.2. Intensive research to offer therapies for dermatological disorders
      • 3.2.3. The increasing number of people affected with dermatological disorders
    • 3.3. Market Restraints
      • 3.3.1. Stringent regulations for getting approvals
      • 3.3.2. The high cost of certain specialized medicines
    • 3.4. Opportunities
      • 3.4.1. The high number of ongoing clinical trials in the field
    • 3.5. Porter's Five Forces Analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. The threat from new entrants
      • 3.5.4. The threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by product type
      • 3.6.2. Market attractiveness analysis, by distribution channel
  •  
  • Chapter 4. Global Prescription Dermatology Therapeutics market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Prescription Dermatology Therapeutics market: company market share, 2017
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Type Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. Research and Development, Regional Expansion
  •  
  • Chapter 5. Global Prescription Dermatology Therapeutics market - Product Type Analysis
    • 5.1. Global Prescription Dermatology Therapeutics market: Product Type overview
      • 5.1.1. Global Prescription Dermatology Therapeutics market revenue share, by Product Type, 2017 and 2024
    • 5.2. Psoriasis Drugs
      • 5.2.1. Global Prescription Dermatology Therapeutics market for Psoriasis Drugs, 2017 - 2024(USD Billion)
    • 5.3. Acne and Rosacea Drugs
      • 5.3.1. Global Prescription Dermatology Therapeutics market for Acne and Rosacea Drugs, 2017 - 2024(USD Billion)
    • 5.4. Dermatitis and Seborrhea Drugs
      • 5.4.1. Global Prescription Dermatology Therapeutics market for Dermatitis and Seborrhea Drugs, 2017 - 2024 (USD Billion)
    • 5.5. Skin Cancer
      • 5.5.1. Global Prescription Dermatology Therapeutics market for Skin Cancer, 2017 - 2024 (USD Billion)
    • 5.6. Fungal Infection Drugs
      • 5.6.1. Global Prescription Dermatology Therapeutics market for Fungal Infection Drugs, 2017 - 2024 (USD Billion)
  •  
  • Chapter 6. Global Prescription Dermatology Therapeutics market - Distribution Channel Analysis
    • 6.1. Global Prescription Dermatology Therapeutics market: Distribution Channel overview
      • 6.1.1. Global Prescription Dermatology Therapeutics market revenue share, by Distribution Channel, 2017 and 2024
    • 6.2. Mail Order Pharmacies
      • 6.2.1. Global Prescription Dermatology Therapeutics market for Mail Order Pharmacies, 2017 - 2024 (USD Billion)
    • 6.3. Retail Pharmacies
      • 6.3.1. Global Prescription Dermatology Therapeutics market for Retail Pharmacies, 2017 - 2024 (USD Billion)
    • 6.4. Hospital Pharmacies
      • 6.4.1. Global Prescription Dermatology Therapeutics market for Hospital Pharmacies, 2017 - 2024 (USD Billion)
  •  
  • Chapter 7. Global Prescription Dermatology Therapeutics market - Regional Analysis
    • 7.1. Global Prescription Dermatology Therapeutics market: Regional overview
      • 7.1.1. Global Prescription Dermatology Therapeutics market revenue share, by region, 2017 and 2024
    • 7.2. North America
      • 7.2.1. North America Prescription Dermatology Therapeutics market revenue, by Product Type, 2017 - 2024(USD Billion)
      • 7.2.2. North America Prescription Dermatology Therapeutics market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
      • 7.2.3. The U.S.
        • 7.2.3.1. The U.S. Prescription Dermatology Therapeutics market revenue, by Product Type, 2017 - 2024(USD Billion)
        • 7.2.3.2. The U.S. Prescription Dermatology Therapeutics market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
      • 7.2.4. Canada
        • 7.2.4.1. Canada Prescription Dermatology Therapeutics market revenue, by Product Type, 2017 - 2024 (USD Billion)
        • 7.2.4.2. Canada Prescription Dermatology Therapeutics market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
      • 7.2.5. Rest of North America
        • 7.2.5.1. Rest of North America Prescription Dermatology Therapeutics market revenue, by Product Type, 2017 - 2024(USD Billion)
        • 7.2.5.2. Rest of North America Prescription Dermatology Therapeutics market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
    • 7.3. Europe
      • 7.3.1. Europe Prescription Dermatology Therapeutics market revenue, by Product Type, 2017 - 2024(USD Billion)
      • 7.3.2. Europe Prescription Dermatology Therapeutics market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
      • 7.3.3. Germany
        • 7.3.3.1. Germany Prescription Dermatology Therapeutics market revenue, by Product Type, 2017 - 2024(USD Billion)
        • 7.3.3.2. Germany Prescription Dermatology Therapeutics market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
      • 7.3.4. U.K.
        • 7.3.4.1. U.K. Prescription Dermatology Therapeutics market revenue, by Product Type, 2017 - 2024(USD Billion)
        • 7.3.4.2. U.K. Prescription Dermatology Therapeutics market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
      • 7.3.5. France
        • 7.3.5.1. France Prescription Dermatology Therapeutics market revenue, by Product Type, 2017 - 2024(USD Billion)
        • 7.3.5.2. France Prescription Dermatology Therapeutics market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
      • 7.3.6. Italy
        • 7.3.6.1. Italy Prescription Dermatology Therapeutics market revenue, by Product Type, 2017 - 2024 (USD Billion)
        • 7.3.6.2. Italy Prescription Dermatology Therapeutics market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
      • 7.3.7. Spain
        • 7.3.7.1. Spain Prescription Dermatology Therapeutics market revenue, by Product Type, 2017 - 2024 (USD Billion)
        • 7.3.7.2. Spain Prescription Dermatology Therapeutics market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
      • 7.3.8. Russia
        • 7.3.8.1. Russia Prescription Dermatology Therapeutics market revenue, by Product Type, 2017 - 2024 (USD Billion)
        • 7.3.8.2. Russia Prescription Dermatology Therapeutics market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
      • 7.3.9. Rest of Europe
        • 7.3.9.1. Rest of Europe Prescription Dermatology Therapeutics market revenue, by Product Type, 2017 - 2024(USD Billion)
        • 7.3.9.2. Rest of Europe Prescription Dermatology Therapeutics market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Prescription Dermatology Therapeutics market revenue, by Product Type, 2017 - 2024(USD Billion)
      • 7.4.2. Asia Pacific Prescription Dermatology Therapeutics market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
      • 7.4.3. China
        • 7.4.3.1. China Prescription Dermatology Therapeutics market revenue, by Product Type, 2017 - 2024(USD Billion)
        • 7.4.3.2. China Prescription Dermatology Therapeutics market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
      • 7.4.4. Japan
        • 7.4.4.1. Japan Prescription Dermatology Therapeutics market revenue, by Product Type, 2017 - 2024(USD Billion)
        • 7.4.4.2. Japan Prescription Dermatology Therapeutics market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
      • 7.4.5. India
        • 7.4.5.1. India Prescription Dermatology Therapeutics market revenue, by Product Type, 2017 - 2024(USD Billion)
        • 7.4.5.2. India Prescription Dermatology Therapeutics market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
      • 7.4.6. Australia
        • 7.4.6.1. Australia Prescription Dermatology Therapeutics market revenue, by Product Type, 2017 - 2024 (USD Billion)
        • 7.4.6.2. Australia Prescription Dermatology Therapeutics market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
      • 7.4.7. Rest of Asia Pacific
        • 7.4.7.1. Rest of Asia Pacific Prescription Dermatology Therapeutics market revenue, by Product Type, 2017 - 2024(USD Billion)
        • 7.4.7.2. Rest of Asia Pacific Prescription Dermatology Therapeutics market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
    • 7.5. Latin America
      • 7.5.1. Latin America Prescription Dermatology Therapeutics market revenue, by Product Type, 2017 - 2024(USD Billion)
      • 7.5.2. Latin America Prescription Dermatology Therapeutics market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
      • 7.5.3. Brazil
        • 7.5.3.1. Brazil Prescription Dermatology Therapeutics market revenue, by Product Type, 2017 - 2024(USD Billion)
        • 7.5.3.2. Brazil Prescription Dermatology Therapeutics market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
      • 7.5.4. Mexico
        • 7.5.4.1. Mexico Prescription Dermatology Therapeutics market revenue, by Product Type, 2017 - 2024 (USD Billion)
        • 7.5.4.2. Mexico Prescription Dermatology Therapeutics market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
      • 7.5.5. Argentina
        • 7.5.5.1. Argentina Prescription Dermatology Therapeutics market revenue, by Product Type, 2017 - 2024 (USD Billion)
        • 7.5.5.2. Argentina Prescription Dermatology Therapeutics market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
      • 7.5.6. Rest of Latin America
        • 7.5.6.1. Rest of Latin America Prescription Dermatology Therapeutics market revenue, by Product Type, 2017 - 2024(USD Billion)
        • 7.5.6.2. Rest of Latin America Prescription Dermatology Therapeutics market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
    • 7.6. The Middle East and Africa
      • 7.6.1. The Middle East and Africa Prescription Dermatology Therapeutics market revenue, by Product Type, 2017 - 2024(USD Billion)
      • 7.6.2. The Middle East and Africa Prescription Dermatology Therapeutics market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
      • 7.6.3. Saudi Arabia
        • 7.6.3.1. Saudi Arabia Prescription Dermatology Therapeutics market revenue, by Product Type, 2017 - 2024 (USD Billion)
        • 7.6.3.2. Saudi Arabia Prescription Dermatology Therapeutics market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
      • 7.6.4. UAE
        • 7.6.4.1. UAE Prescription Dermatology Therapeutics market revenue, by Product Type, 2017 - 2024 (USD Billion)
        • 7.6.4.2. UAE Prescription Dermatology Therapeutics market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
      • 7.6.5. South Africa
        • 7.6.5.1. South Africa Prescription Dermatology Therapeutics market revenue, by Product Type, 2017 - 2024 (USD Billion)
        • 7.6.5.2. South Africa Prescription Dermatology Therapeutics market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
      • 7.6.6. Qatar
        • 7.6.6.1. Qatar Prescription Dermatology Therapeutics market revenue, by Product Type, 2017 - 2024 (USD Billion)
        • 7.6.6.2. Qatar Prescription Dermatology Therapeutics market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
      • 7.6.7. Rest of the Middle East and Africa
        • 7.6.7.1. Rest of the Middle East and Africa Prescription Dermatology Therapeutics market revenue, by Product Type, 2017 - 2024 (USD Billion)
        • 7.6.7.2. Rest of the Middle East and Africa Prescription Dermatology Therapeutics market revenue, by Distribution Channel, 2017 - 2024 (USD Billion)
  •  
  • Chapter 8. Company Profile
    • 8.1. Novartis AG
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Therapy portfolio
      • 8.1.4. Business strategy
      • 8.1.5. Recent developments
    • 8.2. AbbVie, Inc.
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Therapy portfolio
      • 8.2.4. Business strategy
      • 8.2.5. Recent developments
    • 8.3. B. Braun Melsungen AG
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Therapy portfolio
      • 8.3.4. Business strategy
      • 8.3.5. Recent developments
    • 8.4. Amgen, Inc.
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Therapy portfolio
      • 8.4.4. Business strategy
      • 8.4.5. Recent developments
    • 8.5. Janssen Biotech, Inc.
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Therapy portfolio
      • 8.5.4. Business strategy
      • 8.5.5. Recent developments
    • 8.6. Celgene Corporation
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Therapy portfolio
      • 8.6.4. Business strategy
      • 8.6.5. Recent developments
    • 8.7. Eli Lilly and Company
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Therapy portfolio
      • 8.7.4. Business strategy
      • 8.7.5. Recent developments
    • 8.8. Pfizer, Inc.
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Therapy portfolio
      • 8.8.4. Business strategy
      • 8.8.5. Recent developments
    • 8.9. Bausch Health Companies, Inc.
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Therapy portfolio
      • 8.9.4. Business strategy
      • 8.9.5. Recent developments
    • 8.10. LEO Pharma A/S
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Therapy portfolio
      • 8.10.4. Business strategy
      • 8.10.5. Recent developments
    • 8.11. Aurobindo Pharma Ltd.
      • 8.11.1. Overview
      • 8.11.2. Financials
      • 8.11.3. Therapy portfolio
      • 8.11.4. Business strategy
      • 8.11.5. Recent developments
    • 8.12. Sun Pharmaceuticals Ltd.
      • 8.12.1. Overview
      • 8.12.2. Financials
      • 8.12.3. Therapy portfolio
      • 8.12.4. Business strategy
      • 8.12.5. Recent developments

Methodology

Free Analysis

Dermatology deals with diseases that affect hair, skin, and nails. It involves medical as well as surgical aspects. Skin disorders are treated by a dermatologist. Dermatology medicines are available both over-the-counter and on prescription. Many of the prescription dermatology drugs are used for cosmetic purposes. Acne treatment drugs are the most common type of prescription drugs. These drugs are also used to improve the texture and color of the skin. According to the American Academy of Dermatology, acne is the most prevalent skin condition, which affects nearly 50 million Americans annually.

Intensive research to offer therapies for dermatological disorders, increasing number of people affected with dermatological disorders, efforts taken by leading pharmaceutical companies to offer effective treatments, huge investments made in research and development by pharmaceutical companies, and strategic alliances established by companies to speed up the development process of new products are likely to be major growth factors for the global prescription dermatology therapeutics market. Furthermore, rising disposable income, the growing importance of physical appearance, increasing cases of baldness, a rising number of skilled dermatologists, and increasing spending on personal care are others factors that are anticipated to further propel this market’s growth in the future. A high number of ongoing clinical trials in the field and rapid advancements made in the therapies are estimated to create new growth opportunities for the market players. However, stringent regulations regarding approvals, the high cost of certain specialized medicines, and the absence of insurance and reimbursement policies might restrict the prescription dermatology therapeutics market globally in the near future.

Global Prescription Dermatology Therapeutics Market

The global prescription dermatology therapeutics market has been segmented into product type and distribution channel. By product type, the prescription dermatology therapeutics market includes psoriasis drugs, acne and rosacea drugs, dermatitis and seborrhea drugs, skin cancer, and fungal infection drugs. Psoriasis drugs held the majority market share in 2017, due to the increasing cases of psoriasis and prolonged treatment period. The distribution channel segment includes mail order pharmacies, retail pharmacies, and hospital pharmacies.

By region, the North American prescription dermatology therapeutics market is likely to be the most prominent region in the years ahead. This can be attributed to the increasing cases of dermatological disorders and the growing importance of physical appearance in the region. Europe is anticipated to be the second largest prescription dermatology therapeutics market, due to the growing influence of celebrity culture and increasing spending on personal care.

Some key players of the prescription dermatology therapeutics market include Novartis AG, AbbVie, Inc., Amgen, Inc., Janssen Biotech, Inc., Celgene Corporation, Eli Lilly and Company, Pfizer, Inc., Bausch Health Companies, Inc., LEO Pharma A/S, Aurobindo Pharma Ltd., Sun Pharmaceuticals Ltd., and Aclaris Therapeutics, Inc., among others.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social